Human LPAR5 (extracellular) Blocking Peptide (#BLP-LR035) is the original antigen used for immunization during Anti-Human LPAR5 (extracellular) Antibody (#ALR-035) generation. The blocking peptide binds and ‘blocks’ Anti-Human LPAR5 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of human chronic myelogenous leukemia MEG-01 (lanes 1 and 3) and K562 cell lysates (lanes 2 and 4):
- (C)RSKLVAASVPARDRVR, corresponding to amino acid residues 261-276 of human LPA5 receptor (Accession Q9H1C0).